Q2 FY2026 · ended Jun 30, 2026 · Revenue $551.68M, +0.5% YoY · Filed Aug 6, 2026
Icu Medical INC/DE (ICUI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $551.7 million and net income of $19.1 million. Free cash flow was $61.6 million. As of Jun 30, 2026 it held $298.3 million in cash and investments and $1.3 billion in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ICUI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Clemente, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 883984
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $551.7M | $530.2M | $540.7M | $537.0M | $548.9M |
| Operating income | $39.1M | $13.6M | $5.6M | $13.7M | $10.6M |
| Net income | $19.1M | $30.1M | — | -$3.4M | $35.3M |
| Diluted EPS | $0.76 | $1.20 | — | -$0.14 | $1.43 |
| Operating cash flow | $80.2M | $38.9M | $60.6M | $56.7M | $11.2M |
| Free cash flow | $61.6M | $27.6M | $36.0M | $27.6M | -$8.5M |
| Total assets | $4.0B | $4.0B | $4.1B | $4.1B | $4.1B |
| Stockholders' equity | $2.2B | $2.1B | $2.1B | $2.1B | $2.1B |
| Cash and investments | $298.3M | $288.3M | $308.0M | $299.7M | $300.0M |
| Total debt | $1.3B | $1.3B | $1.3B | $1.4B | $1.4B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 18, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 1002 Icu Medical INC/DE SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.